Darunavir Tablet, Film Coated
Product Images NDC 71335-2611

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Darunavir (NDC 71335-2611). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Darunavir-fig-1 (Darunavir Fig 1)

Two side-by-side forest plots comparing pharmacokinetic parameters for Darunavir/Ritonavir dosed twice daily and once daily during the second and third trimesters of pregnancy. Variables include total and unbound AUC and Cmin with geometric mean ratios and 90% confidence intervals shown for each trimester.*

FDA Label Image

Darunavir-structure (Darunavir Structure)

Chemical structure of Darunavir, illustrating its molecular arrangement with multiple rings, hydroxyl groups, and sulfonamide functional groups, corresponding to the active ingredient in the 800 mg film-coated tablet dosage form.*

FDA Label Image

Label (Lbl713352611)

Darunavir Tablets 800 mg film-coated oral tablets in a package of 15 tablets. The label shows NDC 71335-2611-1 and includes storage instructions and warnings. The product is repackaged by Bryant Ranch Prepack, Inc., and manufactured by MSN Laboratories Private Limited.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.